Ivermectin Explained: The Science Behind the Controversy
From The Metabolic Classroom with Dr. Ben Bikman by Insulin IQ
March 23, 2026 · 29 min · Episode 142
About this episode
Dr. Ben Bikman explores the scientific aspects of Ivermectin, a controversial drug, focusing on its effects on metabolism and cancer biology.
📢 Ask Dr. Bikman’s Digital Mind (multilingual): https://benbikman.com/ben-bikmans-digital-ai-mind 📢 Dr. Bikman’s Community & Coaching Site: https://insuliniq.com Topic: Ivermectin is a Nobel Prize-winning drug with emerging evidence showing it influences mitochondria, inflammation, and metabolic signaling pathways such as AMPK and FXR. While most data is still preclinical, its consistent mechanisms and strong safety record make it a compelling candidate for further research in cancer and metabolic disease. Summary: Ivermectin has become one of the most controversial drugs in recent years, but beneath the political noise lies a compelling scientific story. In this lecture, Dr. Ben Bikman examines ivermectin strictly through the lens of peer-reviewed research, highlighting its origins as a Nobel Prize-winning antiparasitic drug and exploring its expanding role in metabolism, mitochondrial function, inflammation, and cancer biology. A central theme of the lecture is ivermectin’s impact on mitochondria, particularly its ability to inhibit complex I of the electron transport chain. This disruption creates an energy crisis within cells, activates AMPK, suppresses mTOR signaling…
People in this episode
Host: Dr. Ben Bikman
Topics covered
- Ivermectin
- metabolism
- mitochondrial function
- inflammation
- cancer biology
- AMPK
- mTOR signaling
Keywords
- Ivermectin
- mitochondria
- AMPK
- cancer
- metabolic signaling
- Nobel Prize
- inflammation
- mTOR
Mentioned in this episode
Organizations: Insulin IQ
Products: Ivermectin
Books & works: Nobel Prize
More episodes of The Metabolic Classroom with Dr. Ben Bikman
- Why Amylin May Be the Most Important Weight Loss Hormone You've Never Heard Of · June 8, 2026 · 21 min
- Why Your Ketone Readings Don’t Match · June 1, 2026 · 29 min
- Why Retatrutide May Outperform GLP-1 Drugs · May 25, 2026 · 27 min
- Why Tirzepatide Works Better Than GLP-1 Alone · May 18, 2026 · 33 min
- The Hidden Signals That Make Fat Cells Grow · May 11, 2026 · 30 min
- Why Neuropathy Isn’t Just About Blood Sugar · May 4, 2026 · 23 min
Explore listener stats, chart rankings, contacts and more on the The Metabolic Classroom with Dr. Ben Bikman podcast page.